Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Content validity of the Familial Chylomicronemia Syndrome Symptoms and Impacts Scale (FCS-SIS) for severe hypertriglyceridemia (sHTG) | Synapse
June 4, 2026
Open Access
Content validity of the Familial Chylomicronemia Syndrome Symptoms and Impacts Scale (FCS-SIS) for severe hypertriglyceridemia (sHTG)
AK
Asia Sikora Kessler
Ionis Pharmaceuticals (United States)
TB
TM Brown
Patient-Centered Outcomes Research Institute
BB
Bonita Basnyat
Patient-Centered Outcomes Research Institute
Ver todo
Puntos clave
To assess the content validity of the Familial Chylomicronemia Syndrome Symptoms and Impacts Scale for patients with severe hypertriglyceridemia.
Conducted a validation study involving patient interviews to gather insights on symptoms and impacts.
Used qualitative analysis to ensure the scale accurately reflects patient experiences related to severe hypertriglyceridemia.
Identified major symptoms and impacts relevant to patients, enhancing the scale's content validity.
Validated FCS-SIS as a reliable tool for measuring the effects of severe hypertriglyceridemia on daily life.
Leer artículo completo
externamente
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Ver artículo completo
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Ver artículo completo
Cite This Study
Copy
Kessler et al. (Wed,) studied this question.
synapsesocial.com/papers/6a211d5cd499ed480b170fe1
https://doi.org/https://doi.org/10.1080/1179271x.2026.2672471